hVIVO delivers rapid, reliable site and recruitment solutions across the UK and Germany, supported by owned clinical sites, specialist recruitment teams, and expert operational leadership. This integrated model enables fast study startup, strong participant engagement, and predictable delivery for Phase I–III trials, including specialist and hard to reach populations.
We also provide proven expertise in challenge studies, specialist cohorts, and complex early-phase research where accelerated timelines and recruitment reliability are essential to success.
35+ years experience conducting early‑phase and challenge studies
Large pre‑screened volunteer database across UK & Germany
Proven success in specialist cohorts and complex studies
Owned sites providing predictable timelines and enhanced recruitment
Single‑site or network delivery (UK & Germany)
Centralised feasibility & site contracting
Swift start‑up & rescue of underperforming studies
Optimised participant engagement via owned sites
Specialist data mining for recruitment optimisation
Participant feedback panels
Processing sites in UK & Germany (including PBMC)
Sponsors conducting Phase 1–3 studies in the UK or Germany
Biotech/pharma requiring fast, reliable start‑up
Teams needing strong recruitment performance or rescue solutions
Programmes requiring specialist cohorts (renal/hepatic, cardiometabolic, asthma/COPD)
Sponsors wanting predictable delivery using owned sites
No R&D approvals, owned sites, centralised contracting and pre‑screened participants compress timelines significantly.
Yes, we have established capability in cardiometabolic, renal/hepatic, asthma and COPD cohorts across UK and Germany.
Yes, our rapid mobilisation and strong recruitment infrastructure make hVIVO an effective rescue option.
Yes, from hVIVO‑owned facilities.
Sign up to our emails and follow us on social media to keep up to date with hVIVO.
